News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Yaky Yanay: Discussing Pluri’s cell therapies with James Roosevelt
Photo collage of Yaky Yanay & James Roosevelt
Oct 27, 2024, 09:03

Yaky Yanay: Discussing Pluri’s cell therapies with James Roosevelt

Yaky Yanay, CEO & President of Pluri Inc, posted the following on X:

“I’m happy to share this interview where I discussed Pluri’s innovative cell therapies alongside James Roosevelt. I also look forward to presenting at Longevity Nation next week, where I’ll share further insights into our work at Pluri.”

cell therapies innovative therapies James Roosevelt Longevity Nation OncoDaily Pluri Yaky Yanay
Special Coverage
Insight
Apr 21, 2025, 19:55
CXCL8, Neutrophils, and Tumor Immunity: Insights by James P. Crowley
Blog
Apr 21, 2025, 19:34
Karin Manchester: When I was told I had leukaemia, I never thought I would still be here 20 years later - ICR
Blog
Apr 21, 2025, 19:12
European School of Oncology Shares New Oncopedia Module on Breast Cancer
Blog
Apr 21, 2025, 18:55
Julie Ince-Demetriou: National Breast Cancer Foundation is hiring science communications specialist
Blog
Apr 21, 2025, 18:19
Lung Cancer Consensus Statement is now officially endorsed by ICC
Blog
Apr 21, 2025, 18:00
Ajlan Al Zaki’s Inspiring Medical Journey Recognized by Alexis Geppner
Insight
Apr 21, 2025, 17:40
Nazik Hammad Publishes Framework on Women, Power, and Cancer in The Lancet
Blog
Apr 21, 2025, 17:35
Stephen Liu: Georgetown Cancer Institute is looking for a sarcoma specialist
Blog
Apr 21, 2025, 17:29
Yan Leyfman: How many future cancers could be linked to CT scans in the U.S.
Blog
Apr 21, 2025, 17:21
Richard Scolyer: Proud of my contributions to the WHO over more than 20 years
Blog
Apr 21, 2025, 17:07
Nehemias Guevara-Rodriguez supports Dr. Narjust Florez’s candidacy for the IASLC Board of Directors
Blog
Apr 21, 2025, 17:04
Taro Yamanaka: DESTINY-Breast09 T-DXd + pertuzumab significantly improved PFS vs. THP in 1L setting